跳转至内容
Merck
CN

740063

壳聚糖

Mv 60,000-120,000

别名:

KiOmedine-CsU® B, 聚（D-氨基葡萄糖）, 脱乙酰几丁质

登录 查看组织和合同定价。

选择尺寸

关于此项目

化学文摘社编号:
9012-76-4
UNSPSC Code:
12352201
MDL number:
MFCD00161512

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

壳聚糖, Mv 60,000-120,000

InChI

1S/C56H103N9O39/c1-87-56(86)65-28-38(84)46(19(10-74)96-55(28)104-45-18(9-73)95-49(27(64)37(45)83)97-39-12(3-67)88-47(85)20(57)31(39)77)103-54-26(63)36(82)44(17(8-72)94-54)102-53-25(62)35(81)43(16(7-71)93-53)101-52-24(61)34(80)42(15(6-70)92-52)100-51-23(60)33(79)41(14(5-69)91-51)99-50-22(59)32(78)40(13(4-68)90-50)98-48-21(58)30(76)29(75)11(2-66)89-48/h11-55,66-85H,2-10,57-64H2,1H3,(H,65,86)/t11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48+,49+,50+,51+,52+,53+,54+,55+/m1/s1

InChI key

FLASNYPZGWUPSU-SICDJOISSA-N

biological source

white mushroom

mol wt

Mv 60,000-120,000

composition

Bacterial endotoxins, ≤10 EU/g
Beta-glucan, ≤5 % (w/w)
Chitosan, ≥93 % (w/w)
Proteins, ≤1 % (w/w)

viscosity

5-200 mPa.s (1% solution in 1% HAc)

solubility

acetic acid: 1% (solution)

storage temp.

2-8°C

正在寻找类似产品? 访问 产品对比指南

Application

与多价阴离子形成凝胶。 产生透明溶液，干燥后形成坚固、透明的薄膜。
Ideal for wound healing and hemostasis; biosurgery and ophthalmology; scaffold and cell therapy; and drug delivery and vaccines

Features and Benefits

生物相容、抗菌和环保的聚电解质，其具有多种应用，包括水处理、色谱法、化妆品添加剂、抗微生物活性的纺织品处理、纺织品的新型纤维、照相纸、可生物降解的薄膜、生物医学装置、以及用于药物递送中控制释放的微胶囊植入物。
生物相容性、抗菌和环保的聚电解质。

General description

乙酰化度: ≤40 mol. %
KiOmedine®-CsU is an ultra-pure chitosan of non-animal origin, produced from white mushrooms (Agaricus bisporus), in accordance with cGMP.
The crystalline structure is in the α-form. The linkage between glucosamine units is β-(1,4).

Legal Information

KitoZyme产品
KiOmedine is a registered trademark of KitoZyme, S.A.

存储类别

11 - Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
STBD5952V
STBD5374V
STBD1418V
STBD1273V
STBC9906V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Chitosan-based Biomaterials."Innovative Polymers Engineered for Drug Delivery and Tissue Engineering
Wu G, et al.
Material Matters, 7(3) null
Alberto Busilacchi et al.
Carbohydrate polymers, 98(1), 665-676 (2013-08-31)
The idea of using chitosan as a functional delivery aid to support simultaneously PRP, stem cells and growth factors (GF) is associated with the intention to use morphogenic biomaterials to modulate the natural healing sequence in bone and other tissues.
Rosanne Raftery et al.
Molecules (Basel, Switzerland), 18(5), 5611-5647 (2013-05-17)
Gene therapy involves the introduction of foreign genetic material into cells in order exert a therapeutic effect. The application of gene therapy to the field of orthopaedic tissue engineering is extremely promising as the controlled release of therapeutic proteins such
D Harikishore Kumar Reddy et al.
Advances in colloid and interface science, 201-202, 68-93 (2013-11-05)
Magnetic chitosan composites (MCCs) are a novel material that exhibits good sorption behavior toward various toxic pollutants in aqueous solution. These magnetic composites have a fast adsorption rate and high adsorption efficiency, efficient to remove various pollutants and they are
Stephanie Supper et al.
Expert opinion on drug delivery, 11(2), 249-267 (2013-12-07)
Thermogelling chitosan (CS)/glycerophosphate (GP) solutions have been reported as a new type of parenteral in situ forming depot system. These free-flowing solutions at ambient temperature turn into semi-solid hydrogels after parenteral administration. Formulation parameters such as CS physico-chemical characteristics, CS/gelling
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持